Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?
作者信息
Jack D B
出版信息
Br J Clin Pharmacol. 1981 Apr;11(4):402-6. doi: 10.1111/j.1365-2125.1981.tb01145.x.
Abstract
摘要
相似文献
1
Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?
Br J Clin Pharmacol. 1981 Apr;11(4):402-6. doi: 10.1111/j.1365-2125.1981.tb01145.x.
2
Preparation and biodistribution of a 125I-labeled beta-adrenoceptor antagonist bearing a cardioselectivity-enhancing N-substituent.
Int J Appl Radiat Isot. 1981 Jun;32(6):429-33. doi: 10.1016/s0020-708x(81)81011-3.
3
4
Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay.
J Pharmacol Exp Ther. 1979 Apr;209(1):153-61.
5
Radioiodinated derivatives of beta adrenoceptor blockers for myocardial imaging.
J Nucl Med. 1978 Aug;19(8):918-24.
6
Synthesis and beta-adrenoceptor blocking activity of thiophenic analogues of metoprolol.
Farmaco Sci. 1986 Jan;41(1):80-8.
7
The determination of beta-adrenoceptor antagonist cardioselectivity "in vivo": atenolol in anaesthetized cats.
Arch Int Pharmacodyn Ther. 1983 Jul;264(1):59-72.
8
Oligomeric and polymeric beta-adrenergic antagonists.
Fed Proc. 1983 Feb;42(2):279-83.
9
Thin-layer chromatographic screening program for commonly used beta-blockers.
Arzneimittelforschung. 1990 Jun;40(6):651-3.
10
Effect of calcium and beta-adrenoceptor antagonists on beta-adrenoceptor density and Gs alpha expression in human atria.
Br J Clin Pharmacol. 1990;30 Suppl 1(Suppl 1):171S-173S. doi: 10.1111/j.1365-2125.1990.tb05497.x.
引用本文的文献
1
Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.
J Pharmacokinet Biopharm. 1984 Jun;12(3):263-87. doi: 10.1007/BF01061721.
2
Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.
Br J Clin Pharmacol. 1982 Aug;14(2):269-72. doi: 10.1111/j.1365-2125.1982.tb01972.x.
3
Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility.
Br J Clin Pharmacol. 1981 Sep;12(3):429-31. doi: 10.1111/j.1365-2125.1981.tb01240.x.
4
Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.
Clin Pharmacokinet. 1987 May;12(5):305-20. doi: 10.2165/00003088-198712050-00001.
本文引用的文献
1
Drug recovery following buccal absorption of propranolol.
Br J Clin Pharmacol. 1980 Jul;10(1):61-5. doi: 10.1111/j.1365-2125.1980.tb00502.x.
2
The clinical importance of cardioselectivity and lipophilicity in beta blockers.
Am Heart J. 1980 Aug;100(2):160-78. doi: 10.1016/0002-8703(80)90112-x.
3
Correlation of serum binding of penicillins with partition coefficients.
Biochem Pharmacol. 1967 Dec;16(12):2275-90. doi: 10.1016/0006-2952(67)90215-8.
4
Pharmacokinetics of pindolol in man.
Eur J Clin Pharmacol. 1974;7(1):17-24. doi: 10.1007/BF00614385.
5
The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.
J Pharmacol Exp Ther. 1973 Jul;186(1):114-22.
6
Binding of two adrenergic beta-receptor antagonists, alprenolol and H 93-26, to human serum proteins.
Acta Pharm Suec. 1974 Sep;11(4):333-46.
7
Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
Naunyn Schmiedebergs Arch Pharmacol. 1973;277(2):211-26. doi: 10.1007/BF00501161.
8
Human pharmacokinetics of sotalol.
Acta Pharmacol Toxicol (Copenh). 1976 Jul;39(1):118-28. doi: 10.1111/j.1600-0773.1976.tb03162.x.
9
Acebutolol disposition after intravenous administration.
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):557-67. doi: 10.1002/cpt1977225part1557.
10
Physico-chemical and anlytical studies of penbutolol.
Arzneimittelforschung. 1979;29(4):602-6.
Zotero 插件